Abstract
HAART-induced immune restoration is beneficial for patients with AIDS-related progressive multifocal leukoencephalopathy (PML). However, in rare instances, an immune-reconstitution inflammatory syndrome (IRIS) may cause paradoxical clinical deterioration. We report the neuropathological study of an AIDS patient who presented with progressive cognitive deterioration; CD4+ count was 117 and the HIV viral load >104; imaging showed non-enhancing lesions consistent with PML. Following initiation of HAART, CD4+ was 300 and HIV viral load <103, but his neurological symptoms continued to deteriorate. Imaging revealed an increase in the size and number of lesions and enhancement of all the lesions. A stereotactic biopsy showed severe inflammatory and demyelinating lesions with marked infiltration by macrophages and T lymphocytes in the absence of a detectable infectious agent. Despite high doses of steroids, the patient died 3 months after admission. Autopsy showed two types of lesions: (1) active inflammatory PML changes with abundant JC virus, and intraparenchymal and perivascular infiltration by T lymphocytes, and (2) acute perivenous leukoencephalitis devoid of JC virus. Most lymphocytes were CD8+ lymphocytes; CD4+ lymphocytes were virtually absent. Two pathological reactions were associated with the paradoxical clinical deterioration related to dysregulation of the immune response characteristic of IRIS in PML: (1) an accentuation of JCV infection, and (2) a nonspecific acute perivenous leukoencephalitis. We suggest that both these types of lesions are due to an imbalance of CD8+/CD4+ T cells, with massive infiltration of the cerebral parenchyma by CD8+ cytotoxic T lymphocytes in the absence of sufficient CD4+ response. Better understanding of the mechanisms of the IRIS may enable prevention or cure of this severe, sometimes fatal complication of HAART.
Similar content being viewed by others
References
Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J (1997) Positive effects of combined antiretroviral therapy on CD4+ T cells homeostasis and function in advanced HIV cases. Science 277:112–116
Berger JR, Levy RM, Flomenhoft D, Dobbs M (1998) Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 44:341–349
Bonnet F, Morlat P, Chene G, Mercie P, Neau D, Chossat I, Decoin M, Djossou F, Beylot J, Dabis F, groupe d’Epidémiologie Clinique du SIDA en Aquitaine (GECSA) (2002) Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998–1999. HIV Med 3:195–199
Breton G, Seilhean D, Chérin P, Herson S, Benveniste O (2002) Paradoxical intracranial cryptococcoma in a human immunodeficiency virus-infected man being treated with combination antiretroviral therapy. Am J Med 113:155–157
Brodt HR, Kkamps BS, Gute P, Knupp B, Staszewski S, Helm EB (1997) Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 11:1731–1738
Cheng VCC, Yuen K-Y, Chan W-M, Wong SSY, Ma ESK, Chan RMT (2000) Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 30:882–892
Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, Marra CM, Francis GM, McArthur JC, Tyler KL, Tselis AC, Hyslop NE (1999) HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 52:623–625
Collazos J, Mayo J, Martinez E, Blanco MS (1999) Contrast enhancing PML as an immune reconstitution event in AIDS patients. AIDS 13:1426–1428
Connick E, Lederman MM, Kotzin BL, Spritzler J, Kuritzkes DR, St Clair M, Sevin AD, Fox L, Chiozzi MH, Leonard JM, Rousseau F, D’Arc Roe J, Martinez A, Kessler H, Landay A (2000) Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response. J Infect Dis 181:358–563
Crump JA, Tyrer MJ, Lloyd-Owen SJ, Han LY, Lipman MC, Johnson MA (1998) Miliary tuberculosis with paradoxical expansion of intracranial tuberculomas complicating immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy. Clin Infect Dis 26:1008–1009
De Simone JA Pomerantz RJ, Babinchak TJ (2000) Inflammatory reactions in HIV-1infected persons after initiation of HAART. Ann Intern Med 133:447–454
Dore G, Correll PK, Ly Y, Kaldor JM, Cooper DA, Brew BJ (1999) Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 13:1249–1253
Du Pasquier RA, Clark KW, Smith PS, Joseph JT, Mazullo JM, De Girolami U, Letvin NL, Koralnik IJ (2001) JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy. J Neurovirol 7:318–322
Foudraine NA, Hovenkamp E, Notermans DW, Meenhorst PL, Klein MR, Lange JM, Miedema F, Reiss P (1999) Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients. AIDS 13:177–184
Gasnault J, Taoufik Y, Goujard C Kousignian P, Abbed K, Boue F, Dussaix E, Delfraissy JF (1999) Prolonged survival without neurological impairment in patients with AIDS-related progressive multifocal leukoencephalopathy on potent compbined antiretroviral therapy. J Neurovirol 5:421–429
Gasnault J, Kahraman M, Goer de Herve MG de, Durali D, Delfraissy JF, Taoufik Y (2003) Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy. AIDS 17:1443–1449
Gay FW, Drye TJ, Dick GW, Esiri MM (1997) The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterisation of the primary demyelinating lesion. Brain 120:1461–1483
Gray F, Chrétien F, Vallat-Decouvelaere AV, Scaravilli F (2003) The changing pattern of HIV neuropathology in the HAART era. J Neuropathol Exp Neurol 62:429–440
Hartung HP, Grossman RI (2001) ADEM: distinct disease or part of MS spectrum? Neurology 56:1257–1260
Hoffmann C, Tabrizian S, Wolf E, Eggers C, Stoehr A, Plettenberg A, Buhk T, Stellbrink HJ, Horst HA, Jager H, Rosenkranz T (2001) Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS 15:2119–2127
Hoffmann C, Horst HA, Albrecht H, Schlote W (2003) Progressive multifocal leukoencephalopathy with unusual inflammatory response during antiretroviral treatment. J Neurol Neurosurg Psychiatry 74:1142–1144
Hogg RS, O’Shaughnessy MV, Gataric N, Yip B, Craib K, Schechter MT, Montaner JS (1997) Decline in deaths from AIDS due to new antiretrovirals. Lancet 349:1294
Jacobson MA, Zegans M, Pavan PR, O’Donnell JJ, Sattler F, Rao N, Owens S, Pollard R (1997) Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 349:1443–1445
Jellinger KA, Setinek U, Drlicek M, Böhm G, Steurer A, Lintner F (2000) Neuropathology and general autopsy findings in AIDS during the last years. Acta Neuropathol 100:213–220
Karavellas MP, Plummer DJ, Macdonald JC, et al (1999) Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful HAART. J Infect Dis 179:697–700
King MD, Perlino CA, Cinnamon J, Jernigan JA (2002) Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy. Int J STD AIDS 13:724–726
Koralnik IJ (2004) New insight into progressive multifocal leukoencephalopathy. Curr Opin Neurol 17:365–370
Kotecha N, George MJ, Smith TW, Corvi F, Litofsky NS (1998) Enhancing progressive multifocal leukoencephalopathy: an indicator of improved immune status? Am J Med 105:541–543
Langford TD, Letendre SL, Marcotte TD, Ellis RJ, McCutchan JA, Grant I, Mallory ME, Hansen LA, Archibald S, Jernigan T, Masliah E, the HNRC group (2002) Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS 16:1019–1029
Masliah E, DeTeresa RM, Mallory ME, Hansen LA (2000) Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 14:69–74
Matloubian M, Concepcion RJ, Ahmed R (1994) CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 68:8056–8063
Miller RF, Isaacson PG, Hall-Craggs M, Lucas S, Gray F, Scaravilli F, An SF (2004) Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART. Acta Neuropathol 108:17–23
Miralles P, Berenguer J, Lacruz C, Cosin J, Lopez JC, Padilla B, Munoz L, Garcia-de-Viedma D (2001) Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy. AIDS 15:1900–1902
Morgello S, Mahboob R, Yakoushina T, Khan S, Hague K (2002) Autopsy findings in human immunodeficiency virus-infected population over 2 decades: influences of gender, ethnicity, risk factors and time. Arch Pathol Lab Med 126:182–190
Neumann H, Medana IM, Bauer J, Lassmann H (2002) Cytotoxic T lymphocytes in autoimmune and degenerative CNS disease. Trends Neurosci 25: 313–319
Nicoll JAR, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO (2003) Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nat Med 9: 448–452
Nuttall JJC, Wilmshurst JM, Ndondo AP, Yeats J, Corcoran C, Hussey GD, Eley BS (2004) Progressive multifocal leukoencephalopathy after initiation of highly active antiretroviral therapy in a child with advanced human immunodeficiency virus infection: a case of immune reconstitutioninflammatory syndrome. Pediatr Infect Dis J 23:683–685
Pakker NG, Ross MTL, Leeuwen R van, Jong MD de, Koot M, Reiss P, lange JM, Miedema F, Danner SA, Schellekens PT (1997) Patterns of T-cell repopulation, virus load replication, and restoration of T-cell function on HIV-infected persons during therapy with different antiretroviral agents. J Acquir Immune Defic Syndr Hum Retrovirol 16:318–326
Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC (2001) HIV associated neurologic disease incidence changes: Multicenter AIDS cohort study, 1990–1998. Neurology 56:257–260
Safdar A, Rubocki RJ, Horvath JA, Narayan KK, Waldron RL (2002) Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution. Clin Infect Dis 35:1250–1257
Scaravilli F, Esiri M, Sharer L, Gray F (2004) Infections of the central nervous system. In: Gray F, DeGirolami U, Poirier J (eds) Escourolle and Poirier Manual of Basic Neuropathology, 4th edn, Chapter 5. Butterworth Heinemann, Philadelphia, pp 113–144
Schmidbauer M, Budka H, Shah KV (1990) Progressive multifocal leukoencephalopathy (PML) in AIDS and in the pre-AIDS era. A neuropathological comparison using immunocytochemistry and in situ DNA hybridisation for virus detection. Acta Neuropathol 80:375–380
Shelburne SA, Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atmar RL, Musher DW, Gathe JC Jr, Visnegarwala F, Trautner BW(2002) Immune reconstitution inflammatory syndrome. Emergence of a unique syndrome during HAART. Medicine 81:213–227
Tantisiriwat W, Tebas P, Clifford DB, Powderly WG, Fichtenbaum CJ (1998) Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy. Clin Infect Dis 28:1152–1154
Tassié JM, Gasnault J, Bentata M, Deloumeaux J, Boué F, Billaud E, Costagliola D, the French Hospital Database on HIV (1999) Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. AIDS 13:1881–1887
Vago L, Bonetto S, Nebuloni M, Duca P, Carsana L, Zerbi P, D’Arminio-Monforte A (2002) Pathological findings in the CNS of AIDS patients on assumed ART regimens: retrospective study of 1597 autopsies. AIDS 16:1925–1928
Vallat-Decouvelaere AV, Chrétien F, Lorin de la Grandmaison G, Carlier R, Force G, Gray F (2003) La pathologie du système nerveux central liée au VIH à l’ère des multithérapies. Ann Pathol 23:408–423
Woods ML, MacGinley R, Eisen DP, Allworth AM (1998) HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection. AIDS 12:1491–1494
Acknowledgements
Supported by grants to Dr. Gray from Agence Nationale de Recherches sur le SIDA (ANRS) and Ensemble Contre le SIDA (ECS). The authors wish to thank Dr. Catherine Keohane for kindly reviewing the English, Dr. Patrice LeFloch-Progent in the Service Central d’Anatomie et Cytologie Pathologiques at Hôpital Cochin (Pr. M.C. Vacher-Lavenu) who performed the autopsy, and Marie-Annick Bretel, Patrice Castagnet, Katia Dossou, Isabelle Levesque and Claudine Poron, for histological preparations.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vendrely, A., Bienvenu, B., Gasnault, J. et al. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol 109, 449–455 (2005). https://doi.org/10.1007/s00401-005-0983-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-005-0983-y